1-deoxynojirimycin has been researched along with Hyperlipidemias in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aerts, JM; Bietrix, F; Groen, AK; Lombardo, E; Ottenhoff, R; Rensen, PC; van Roomen, CP; Verhoeven, AJ; Vos, M | 1 |
| Bhatia, G; Chaturvedi, U; Saxena, JK; Shrivastava, A; Singh, SV | 1 |
| Aller, R; Conde Valentín, R; de Luis Román, DA; del Pozo García, E; Romero Bobillo, E | 1 |
3 other study(ies) available for 1-deoxynojirimycin and Hyperlipidemias
| Article | Year |
|---|---|
Inhibition of glycosphingolipid synthesis induces a profound reduction of plasma cholesterol and inhibits atherosclerosis development in APOE*3 Leiden and low-density lipoprotein receptor-/- mice.
Topics: 1-Deoxynojirimycin; Adamantane; Animals; Apolipoproteins E; Atherosclerosis; Bile; Cholesterol; Disease Models, Animal; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Inhibitors; Feces; Female; Glucosyltransferases; Glycosphingolipids; Hyperlipidemias; Kinetics; Liver; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Mutation; Receptors, LDL | 2010 |
Lipid lowering and antioxidant effect of miglitol in triton treated hyperlipidemic and high fat diet induced obese rats.
Topics: 1-Deoxynojirimycin; 3T3-L1 Cells; Adipogenesis; Animals; Antioxidants; Body Weight; Diet, High-Fat; Eating; Hyperlipidemias; Hypoglycemic Agents; Lipids; Liver; Male; Mice; Obesity; Polyethylene Glycols; Rats | 2013 |
[Usefulness of miglitol in patients with diabetes mellitus type 2 and insufficient control of the blood glucose].
Topics: 1-Deoxynojirimycin; Aged; Aged, 80 and over; Diabetes Mellitus, Type 2; Female; Glucosamine; Humans; Hyperlipidemias; Hypoglycemic Agents; Imino Pyranoses; Lipids; Male; Middle Aged; Treatment Outcome | 2004 |